Related Experiment Video

Updated: May 1, 2026

Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model
05:31

Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model

Published on: June 8, 2022

2.7K

[Aortic valve replacement after percutaneous transcatheter aortic valvuloplasty for severe aortic stenosis]

Tetsuro Uchida1, Cholsu Kim, Yoshiyuki Maekawa

  • 1econd Department of Surgery, Yamagata University Faculty of Medicine, Yamagata, Japan.

Kyobu Geka. the Japanese Journal of Thoracic Surgery
|April 19, 2014
PubMed

Insights

Surgical aortic valve replacement (AVR) after percutaneous transcatheter aortic valvuloplasty (PTAV) is safe and effective for high-risk patients with severe aortic stenosis. PTAV serves as a valuable bridge to AVR or palliative treatment.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Interventional Cardiology

Context:

  • Severe aortic stenosis (AS) often necessitates aortic valve replacement (AVR).
  • Elderly patients with comorbidities may be unsuitable for direct AVR.
  • Percutaneous transcatheter aortic valvuloplasty (PTAV) offers palliative or bridge therapy for AS.

Purpose:

  • To evaluate the effectiveness and clinical outcomes of surgical AVR following PTAV.
  • To assess the safety and feasibility of AVR in patients previously treated with PTAV.

Summary:

  • Five high-risk patients with severe AS underwent AVR after PTAV between 2010 and the study period.
  • PTAV was used as a bridge to AVR in two patients, for restenosis in two, and prior to non-cardiac surgery in one.
  • All patients experienced improved cardiac hemodynamics post-AVR, with no operative mortality and uneventful recovery.

Impact:

  • Surgical AVR can be safely performed in high-risk patients with a history of PTAV.
  • PTAV is a viable option for palliation or as a bridge to definitive AVR in patients unsuitable for initial surgery.
Abstract

More Related Videos

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots12:17

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots

Published on: May 21, 2017

10.5K
Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement08:50

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement

Published on: March 26, 2018

10.9K

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
535
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
598